PIRPHYTO

Piramal Phytocare Limited has informed the Exchange regarding Board meeting held on May 07, 2019.

Piramal Phytocare Limited has informed the Exchange regarding Board meeting held on February 05, 2019.

Piramal Phytocare Limited has informed the Exchange regarding Board meeting held on November 02, 2018.

Piramal Phytocare Limited has informed the Exchange regarding Board meeting held on August 02, 2018.

Piramal Phytocare Limited has informed the Exchange regarding Board meeting held on May 28, 2018.

Piramal Phytocare Limited has informed the Exchange regarding Outcome of Board Meeting held on January 31, 2018.

Piramal Phytocare Limited has informed the Exchange regarding Outcome of Board Meeting held on January 31, 2018.

Piramal Phytocare Limited has informed the Exchange that Outcome of Board Meeting held April 26, 2017: 1. Change in Statutory Auditors of the Company 2. Change in date of Annual General Meeting.

Piramal Phytocare Limited has informed the Exchange regarding the Outcome of Board Meeting held on April 12, 2017

Piramal Phytocare Limited has informed the Exchange that the Board of Directors, at its meeting held on February 8, 2017 has Appointed Mr. Rajiv Salvi was appointed as the Manager of the Company for a period of 3 years with effect from February 08, 2017.

Piramal Phytocare Limited has informed the Exchange the 15th Annual General Meeting of the Company is scheduled to be held on August 04, 2016.

Piramal Phytocare Limited has informed the Exchange that the Board of Directors of the Company at its Meeting held on October 24, 2013 took on record resignation of Dr. Somesh Sharma who has step down as Director of the Company. The Board of Directors have placed on record their appreciation and gratitude for the invaluable contributions made by Dr. Somesh Sharma during his tenure as member of the Board.

Piramal Life Sciences Limited had informed the Exchange that a meeting of the Board of Directors of the Company will be held on October 13, 2011 to consider and take on record the Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2011. The Company has now informed the Exchange that the in view of paucity of time, it was decided that the results for the quarter ended September 30, 2011 be considered at a subsequent meeting for which necessary advance intimation would be given by the Company.

Piramal Life Sciences Limited has informed the Exchange that at its meeting held on May 6, 2011, the Board considered and approved the Scheme of Arrangement between Piramal Life Sciences Limited (`PLSL') and Piramal Healthcare Limited ('PHL') (`Demerger Scheme'). Under the proposed Demerger Scheme, the New Chemical Entity (NCE) Research Unit would be transferred from PLSL to PHL with effect from April 1, 2011, which is the Appointed Date under the Demerger Scheme. The following exchange ratio has been approved: "1 [one] fully paid up equity shares of Rs. 2/- of PHL shall be issued and allotte